ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
Top brokers name 3 ASX shares to buy next week
Growth Shares
Where I would invest $1,000 in ASX shares today
Share Market News
Here's why brokers are turning bullish on the CSL share price again
Share Market News
Futures traders are betting heavily on an RBA rate cut tomorrow: 4 shares to profit
Share Gainers
ResApp share price surges 11% higher on positive update
Growth Shares
Where to invest $20,000 in ASX 200 shares in October
⏸️ ASX Shares
10 ASX blue chip shares to own in 2020
Share Market News
Where I would reinvest my BHP dividends
⏸️ ASX Shares
10 quality ASX shares to buy for 2020
Healthcare Shares
Is the CSL share price still a buy?
Growth Shares
3 outstanding ASX healthcare shares to bring your portfolio to life
Share Market News
Leading broker names 7 high conviction ASX shares to buy in September
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
